Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival
Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam
Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval
Trastuzumab Increases Risks Of Congestive Heart Failure
Breast Density Does Not Raise Breast Cancer Death Rates
Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine
Spectral Mammography “Like Color vs. Black & White TV”
Study Reveals Racial Disparities In Surgical Prostate Care
2,000 Breast Cancer Recurrence Biomarker Candidates Discovered
NCI Approved CTEP Trials For the Month of August
FDA Approves Afinitor Tablets For Advanced Breast Cancer
Afinitor Suspension Approved For Rare Pediatric Brain Tumor
FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer
Trending Stories
- NCI paylines to drop to 9th percentile amid CRs and uncertainty
- Brian Druker steps down as CEO of OHSU Knight Cancer Center
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - An NCI initiative focuses on early-onset cancers
- An elephant in the room: Grief in young adults with cancer
- Weeks before death from sarcoma, Norm Coleman reflected on his career in radiation oncology and addressing health disparities
